FDA gives nod of approval to first derived mesenchymal stromal cell therapy for the treatment of pediatric patients with ...
From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.
Ensartinib has received FDA approval for the first-line treatment of ALK-positive locally advanced or metastatic non–small ...
Pharmacologic strategies may be able to prevent abnormal uterine bleeding in patients undergoing stem cell transplant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback